We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.


4 August 2009 By John Foley

Months after a rights issue, the emergingmarkets lender is raising £1bn in a placing. At worst, this will absorb rising bad debts. At best, it could provide growth capital for StanChart s embryonic investment banking franchise. Either way, the opportunistic move should pay off.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)